Journal of the American College of Cardiology
Volume 53, Issue 5, Supplement, 3 February 2009, Pages S28-S34
State-of-the-Art PaperCardiovascular Therapies and Associated Glucose Homeostasis: Implications Across the Dysglycemia Continuum
Under an Elsevier user license
open archive
Key Words
metabolic syndrome
pre-diabetes
thiazide diuretic
dysglycemia
glucose homeostasis
Abbreviations and Acronyms
ACE
angiotensin-converting enzyme
ARB
angiotensin receptor blocker
BP
blood pressure
CAD
coronary artery disease
CHD
coronary heart disease
CV
cardiovascular
HDL-C
high-density lipoprotein cholesterol
IFG
impaired fasting glucose
IGT
impaired glucose tolerance
MetSyn
metabolic syndrome
RAAS
renin-angiotensin-aldosterone system
Cited by (0)
This work supported in part by National Institutes of Health grant (5K23HL086558). Drs. Cooper-DeHoff and Pacanowski have no conflicts of interest to report. Dr. Pepine has received grant/research support from or has consultant agreements with AstraZeneca, Boehringer Ingelheim, CV Therapeutics Inc, Pfizer Inc, sanofi-aventis, Schering-Plough, Daiichi Sankyo Inc, Eli Lilly and Company, and Merck & Co. Inc.
Copyright © 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.